Following on from its recent signing of melanoma vaccine client, Scancell, Schwartz Communications UK has signed three oncology accounts.
– UK-based Microsulis, which uses microwave technology to destroy previously inoperable tumours
– global health science company MDS Nordion which provides products and services used for the prevention, diagnosis and treatment of disease, specifically liver cancer treatments
– South Korea-based KAEL-GemVax, which is developing new cancer vaccines to enhance survival while maintaining a high quality of life for patients
[lnk|http://www.schwartzcomm.com|_blank|Schwartz Communications UK Limited]